Clinical Trials Logo

Clinical Trial Summary

Good bone healing and bone build-up are necessary for the success of dental implants. Research in animals and humans has shown that a drug, called Forteo, can increase bone build-up and bone strength over time. Forteo has been approved by the Food and Drug Administration (FDA) for use in patients with a condition where bone is broken down and weakened, called osteoporosis. The investigators do not know, however, whether Forteo is effective for use in humans for improving bone healing after implant placement, and whether it will have the same bone-building and bone-strengthening effects as for patients with osteoporosis. This research study is being done to learn what effect 7 weeks of treatment with Forteo will have on bone build-up and strengthening of bone for patients receiving implants.


Clinical Trial Description

A single center, placebo-controlled, double blind parallel study of teriparatide use in patients requiring dental implant therapy is planned. Subjects who qualify based on the inclusion/exclusion criteria will be randomly placed into one of two treatment groups, teriparatide (20 μg/day) or placebo control. Both patients and investigators will be blinded. Serum and gingival crevicular fluid (GCF) samples, radiographs, and a tetracycline-labelled bone core will constitute the main data gathered for analysis. After implant surgery, patients will return at 2 weeks for post-operative care and then at 14 weeks for an implant impression and again at 16 weeks to receive the final restoration. Twelve months after implant placement, patients will be seen for a follow-up exam and standardized radiograph to ensure proper healing. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01279187
Study type Interventional
Source University of Michigan
Contact
Status Terminated
Phase Phase 2
Start date February 2011
Completion date November 2015

See also
  Status Clinical Trial Phase
Completed NCT03784430 - Soft and Hard Tissue Changes After Immediate Single-tooth Replacement N/A
Completed NCT02096978 - Comparing Implant Stability Using Two Accepted Techniques for Implant Sites N/A
Completed NCT04048239 - Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation N/A
Recruiting NCT06150768 - Porcelain-fused-to-metal Versus Zirconia Implant- Supported in Mandibular Kennedy Class II N/A
Completed NCT02175550 - A 5-year Clinical Evaluation Study on NobelReplace Conical Connection Implants N/A
Completed NCT01066780 - ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users N/A
Completed NCT05190614 - Radiographic Evaluation of a Star-shaped Incision Technique
Completed NCT04706078 - Clinical and Radiographic Evaluation of a Cross-shaped Incision Technique
Recruiting NCT04935944 - Effect of FOV and mA on Metal Artifacts on CBCT
Not yet recruiting NCT05387421 - Evaluating the PrimeTaper EV Implant for 5 Years N/A
Terminated NCT02373787 - A 5 Year Clinical Investigation on Creos Xenoprotect N/A
Completed NCT05869292 - Immediate Vs. Early Loading of Immediately Placed Implants N/A
Active, not recruiting NCT04027660 - Outcome of Immediate Zirconia Implants
Completed NCT02861313 - Oral Health Related Quality of Life and Peri-implant Condition in Single Implant Overdenture N/A
Not yet recruiting NCT05723926 - Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation N/A
Completed NCT03100448 - A 1-year Clinical Investigation on the On1 Concept N/A
Completed NCT02362854 - Efficacy of Diode Laser in Peri-implantitis N/A
Terminated NCT04676061 - Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™ Phase 4
Recruiting NCT04942327 - Awareness Among Hearing Enhancement Interventions and Reimbursement Criteria of Hearing Implants N/A
Recruiting NCT05768295 - Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants N/A